Press Releases

Title	Topic	Date
Regulatory Expert Henrietta Ukwu, M.D. Appointed Novavax Chief Regulatory and Quality Officer		1/15/2021
Novavax Finalizes Agreement with Commonwealth of Australia for 51 Million Doses of COVID-19 Vaccine	COVID-19	1/7/2021
Novavax to Participate in Upcoming Conferences	Corporate and Finance	1/6/2021
Novavax Announces Initiation of PREVENT-19 Pivotal Phase 3 Efficacy Trial of COVID-19 Vaccine in the United States and Mexico	COVID-19	12/28/2020
Biopharma Executive Rick Crowley Joins Novavax as Chief Operations Officer	Corporate and Finance	12/21/2020
Novavax Announces Agreement with Government of New Zealand for 10.7 Million Doses of COVID-19 Vaccine	COVID-19	12/16/2020
Novavax Appoints Vaccine Industry Expert Margaret G. McGlynn to Board of Directors	Corporate and Finance	12/9/2020
Novavax Announces COVID-19 Vaccine Clinical Development Progress	COVID-19	11/30/2020
Novavax to Participate in Upcoming Conferences	Corporate and Finance	11/25/2020
Novavax to Host Conference Call for Questions Related to Third Quarter Financial and Operating Results on November 10, 2020	Corporate and Finance	11/10/2020